Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(17/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(17/week)
News
United States
(593/week)
Manufacturing
(401/week)
Energy
(303/week)
Technology
(414/week)
Environment
(248/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Type I hypersensitivity
Nov 07, 2019
Survey Shows People Who First Developed Atopic Dermatitis Symptoms As Kids Experience More Severe Symptoms
Oct 29, 2019
Bryn Pharma Presents Data Demonstrating Patient Preference for Bi-dose Epinephrine Nasal Spray over EpiPen®
Oct 24, 2019
Dr. Derek V. Chan, Dermatologist with Advanced Dermatology PC, Shares Tips on Five Common Rash-Causing Skin Conditions
Oct 24, 2019
Bryn Pharma Raises $17.5 Million in Financing as it Advances Toward U.S. Application to Market Bidose Epinephrine Nasal Spray for Anaphylaxis
Oct 14, 2019
Hoth Therapeutics Makes Donation to National Eczema Association in Sponsorship of "National Eczema Awareness Month"
Oct 10, 2019
2019 European Dermatological Congress: La Roche-Posay Presents Its Latest Research On Allergies, Atopic Dermatitis & Acne
Oct 10, 2019
Bryn Pharma Completes Dosing in Pivotal Clinical Trial Designed to Support U.S. Approval of Intranasal Epinephrine Spray
Oct 08, 2019
Hoth Therapeutics Successfully Completes Phase I of In-Life Dose Escalation Study for Treating Eczema
Oct 03, 2019
Turn Therapeutics(TM) Closes Series B Round to Fuel Lead Atopic Dermatitis Program Trial and Pipeline Expansion
Oct 01, 2019
The National Eczema Association (NEA) Mobilizes Stakeholders To Expose The "Real" Eczema, A Life-Altering Skin Disease Affecting Over 31 Million Americans
Sep 20, 2019
CHMP Recommends Approval of Dupixent® (dupilumab) for Severe Chronic Rhinosinusitis with Nasal Polyposis
Sep 18, 2019
Educational Campaign Helps Teens and Their Caregivers Tackle Everyday Challenges of Living with Moderate-to-severe Atopic Dermatitis
Sep 06, 2019
Recent Studies Reveal Flare Rates Among Dupixent-Treated Patients with Moderate-to-Severe Atopic Dermatitis
Aug 19, 2019
Eczema Impacts Physical and Mental Health of 31M Americans
Aug 09, 2019
Windgap Medical Announces Partnership with ALK-Abelló for its Epinephrine Autoinjector
Aug 06, 2019
Dupixent® (dupilumab) Showed Positive Topline Results in Phase 3 Trial of Children Aged 6 to 11 Years with Severe Atopic Dermatitis
Aug 06, 2019
Dupixent® (dupilumab) Approved by European Commission for Adolescents with Moderate-to-Severe Atopic Dermatitis
Jul 29, 2019
Kindred Biosciences Announces Positive Results from Pilot Field Effectiveness Study of its Interleukin-31 Monoclonal Antibody for the Treatment of Atopic Dermatitis in Dogs
Jul 19, 2019
Statement from Health Canada on the supply of EpiPen 0.3 mg auto-injectors
Jun 28, 2019
CHMP Recommends Approval of Dupixent® (dupilumab) for Moderate-to-Severe Atopic Dermatitis in Adolescents
‹‹
Page 2
››
Latest News
Apr 24, 2024
Sturm, Ruger & Company, Inc. to Report First Quarter 2024 Financial Results on Tuesday, May 7
Apr 24, 2024
Encore Wire Reports First Quarter Results
Apr 24, 2024
Novo Oil & Gas II Receives Equity Capital Commitment from EnCap Investments
Apr 24, 2024
Advent Technologies Holdings Receives Nasdaq Notice on Late Filing of its Form 10-K
Apr 24, 2024
Ranger Energy Services, Inc. Announces Date for First Quarter 2024 Earnings Conference Call
Apr 24, 2024
Crescent Energy Schedules First Quarter 2024 Earnings Release and Conference Call
Apr 24, 2024
American States Water Company to Report First Quarter 2024 Results
Apr 24, 2024
Seadrill Announces First Quarter 2024 Earnings Release and Conference Call
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events